Tag: Conjugate

Europe Conjugate Vaccine Market to Boost Business Scope with Key Players

The MarketWatch News Department was not involved in the creation of this content.

Sep 13, 2020 (AmericaNewsHour) —
Europe Conjugate Vaccine Market:

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases.Europe is a market with stable growth for conjugate vaccines. The conjugate vaccine market in Europe is expected to expand at a CAGR of 3.6% leading to a revenue of USD 8.94 Bn by 2023. By volume, it is anticipated to reach 504.46 Million units by 2023, expanding at a CAGR of 3.7%. The U.K. was the first country to introduce MenB-4C into their National Infant Immunization Program (2015). In all EU/EEA countries, Hib vaccination has been part of the immunization programs, since 2010, and high coverage has been sustained.

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10009588

Market Segmentation:

  • Based on disease indication, the market
Read More

Conjugate Vaccines Market Top Business Strategies, Technological Innovation and Emerging Trends of Outlook To 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 10, 2020 (Market Insight Reports) —
Selbyville, Delaware The Global Conjugate Vaccines Market 2020 Research Report investigates the industry thoroughly and offers a complete study on Conjugate Vaccines volume, market Share, market Trends, Global Conjugate Vaccines Growth aspects, wide range of applications, Utilization ratio, Supply and demand analysis, manufacturing capacity and Price trends and Forecast from 2020 to 2026

Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein. This protein has a key role in enhancing the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis. The global Conjugate Vaccines market is valued at 11550 million US$ in 2020 is expected to reach 16820 million

Read More